Structure Info
- Chemspace ID
- CSCS06595022253 (Synthesis)
- IUPAC Name
- (10R,11R,15S,16S)-10-(4-hydroxy-3,5-dimethoxyphenyl)-16-[(4-nitrophenyl)amino]-4,6,13-trioxatetracyclo[7.7.0.0³,⁷.0¹¹,¹⁵]hexadeca-1,3(7),8-trien-12-one
- Mol formula
- C27H24N2O9
- Mol weight
- 520 Da
- Catalog Number(s)
- HY-19188, JH110231, T27414
- Copy structure to query editor
- SMILES
- INCHI
- INCHI key
- MOL
Properties
- LogP
- 3.38
- Heavy atoms count
- 38
- Rotatable bond count
- 6
- Number of rings
- 6
- Carbon bond saturation, Fsp3
- 0.296
- Polar surface area (Å)
- 139
- Hydrogen bond acceptors count
- 9
- Hydrogen bond donors count
- 2
- Zoom the structure
- CSCS06595022253
Items Overall 5 items from 3 suppliers
| Supplier | Lead time | Ships from | Purity | Pack | Price, € | Qty |
|---|---|---|---|---|---|---|
| Targetmol Chemicals Inc | 30 days | United States To: | 90 | 25 mg | 1,520 | |
| Targetmol Chemicals Inc | 30 days | United States To: | 90 | 50 mg | 1,980 | |
| Targetmol Chemicals Inc | 30 days | United States To: | 90 | 100 mg | 2,500 | |
Description: GL-331, a DNA topoisomerase II inhibitor, is used potentially for the treatment of small cell lung cancer and gastric cancer.; CAS: 127882-73-9 | ||||||
| MedChemExpress | TBD | United States To: | 90 | 1 mg | POA | |
Description: Names: GL-331; Product Description: GL-331 is a potent anti-cancer agent. GL-331 has demonstrated more efficacious anti-cancer activity in both the in vitro and in vivo lymphoma systems .; Target: Apoptosis; CAS: 127882-73-9 | ||||||
| MedChemExpress EU | TBD | Sweden To: | 90 | 1 mg | POA | |
Description: Names: GL-331; Product Description: GL-331 is a potent anti-cancer agent. GL-331 has demonstrated more efficacious anti-cancer activity in both the in vitro and in vivo lymphoma systems; Target: Apoptosis; CAS: 127882-73-9 | ||||||
For a custom pack size or bulk
please drop us a line:Enquire
please drop us a line:Enquire